Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paesmans

Showing results (141-150 of 187) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancerA Di Leo, J Crown, J M Nogaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2007
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trialA Di Leo, M Tanner, C Desmedt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutionsA F Ferreira Filho, A Di Leo, M Paesmans, et al.
British Journal of Cancer|July 3, 2003
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysisB Martin, M Paesmans, T Berghmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapyA Hendlisz, V Golfinopoulos, C Garcia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trialA Demols, I Borbath, M Van den Eynde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patientsC Bernard-Marty, M Mano, M Paesmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
The European Respiratory Journal|May 31, 2011
Validation and comparison of several published prognostic systems for patients with small cell lung cancerM Paesmans, J J Lafitte, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2008
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancerT Berghmans, P Van Houtte, M Paesmans, et al.
Pageof 19

Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancerA Di Leo, J Crown, J M Nogaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2007
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trialA Di Leo, M Tanner, C Desmedt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutionsA F Ferreira Filho, A Di Leo, M Paesmans, et al.
British Journal of Cancer|July 3, 2003
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysisB Martin, M Paesmans, T Berghmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapyA Hendlisz, V Golfinopoulos, C Garcia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trialA Demols, I Borbath, M Van den Eynde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patientsC Bernard-Marty, M Mano, M Paesmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
The European Respiratory Journal|May 31, 2011
Validation and comparison of several published prognostic systems for patients with small cell lung cancerM Paesmans, J J Lafitte, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2008
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancerT Berghmans, P Van Houtte, M Paesmans, et al.
Pageof 19